Prospective Data Collection Initiative on Thoracic Malignancies

RecruitingOBSERVATIONAL
Enrollment

12,000

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

January 1, 2029

Study Completion Date

January 1, 2030

Conditions
Lung CancerThoracic CancerLung Cancer, Nonsmall CellAdenocarcinomaSquamous Cell CarcinomaLarge Cell Lung CancerThymus CancerMesothelioma
Interventions
BEHAVIORAL

Health-related quality of life and treatment outcome questionnaires

Patients who consented to the completion of questionnaires will be invited to complete questionnaires on multiple time points but not more often than once every 3 months. The length of time required for the completion of questionnaires will not exceed 150 minutes a year.

GENETIC

(Tumor) tissue and other biomaterials

Tissue and other biomaterial, such as pleural effusion, is collected from material obtained during a diagnostic procedure or surgical resection. No additional interventional procedures are performed to obtain the material.

PROCEDURE

Blood samples

Blood samples can be withdrawn on multiple time points with a maximum of 10 tubes of 10 ml per year during routine blood withdrawals (or in exceptional cases with an additional blood withdrawal).

Trial Locations (1)

Unknown

RECRUITING

UMC Utrecht, Utrecht

All Listed Sponsors
lead

Dutch Society of Physicians for Pulmonology and Tuberculosis

OTHER

NCT06996249 - Prospective Data Collection Initiative on Thoracic Malignancies | Biotech Hunter | Biotech Hunter